Form 4: Guardant Health Executive AmirAli Talasaz Reports Stock Transactions

AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, reported transactions involving the acquisition and disposal of company stock and restricted stock units.

Summary

• AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On December 31, 2024, Talasaz acquired 11,462 shares of common stock and disposed of 5,809 shares to cover tax obligations.
• On January 1, 2025, he acquired 94,555 shares of common stock and disposed of 43,309 shares for tax obligations.
• These transactions also involved the vesting of restricted stock units granted on March 18, 2024.
• The reported transactions resulted in a net increase in Talasaz's holdings of common stock to 2,261,331 shares.

Sentiment

Score: 5

Explanation: The document reflects standard executive stock transactions, which are neither positive nor negative in themselves.

Positives

• The acquisition of shares through vesting indicates a continued alignment of the executive's interests with the company's performance.
• The vesting of restricted stock units is a standard form of compensation for executives.

Negatives

• The disposal of shares to cover tax obligations, while standard, reduces the executive's overall holdings.

Risks

• There are no specific risks mentioned in this document, as it is a standard filing for stock transactions by an executive.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies.

Comparison to Industry Standards

• The vesting of restricted stock units and subsequent tax-related disposals are standard practices for executive compensation in publicly traded companies.
• Similar filings are regularly made by executives at comparable companies such as Exact Sciences and Illumina.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.

Key Dates

Keywords

Form 4, Guardant Health, AmirAli Talasaz, stock transactions, restricted stock units, executive compensation, beneficial ownership